Home / Recalls / Medical Devices
Dexcom Inc recalls Dexcom G6 Continuous Glucose Monitoring System The Dexcom G4 PLATINUM Continuous Glucose Monitoring System is a gluco
Recalled April 1, 2020 · FDA recall Z-1562-2020 · Dexcom
Hazard
The company identified potential interference from hydroxyurea. Patient use of the anti-neoplastic drug may falsely elevate glucose readings on the Continuous Glucose Monitoring Systems. · FDA Class II
Units
275583
Sold at
World-wide Distribution
Description
The company identified potential interference from hydroxyurea. Patient use of the anti-neoplastic drug may falsely elevate glucose readings on the Continuous Glucose Monitoring Systems.
Product
Dexcom G6 Continuous Glucose Monitoring System The Dexcom G4 PLATINUM Continuous Glucose Monitoring System is a glucose monitoring device indicated for detecting trends and tracking patterns in persons (age 18 and older) with diabetes.
Manufacturer(s)
Dexcom Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →